
Audio By Carbonatix
Young men could be risking their sexual health by taking the world's best selling anti-baldness drug, claim some doctors.They say finasteride - sold in the UK as Propecia - can cause serious side effects and that the drug's labelling is inadequate.Male pattern baldness affects six and a half million people in the UK. It's estimated that a quarter of men will start showing signs in their twenties.James, 26, from Edinburgh was one of them."I noticed hair loss, hair coming out in the shower and on the pillow, and I freaked out basically."I went onto the internet and researched it. I found out there was a drug called Propecia, and soon enough I started buying that and it worked a treat."The prescription pill is extremely effective at stopping hair loss and in clinical trials nine out of 10 men didn't lose any more hair over a five year period.Drugs' company Merck, which manufactures Propecia, claims on its website that less than 2% of men could suffer sexual side effects.'Completely impotent'It mentions things like difficulty achieving an erection, but says the problems will go away for men who stop taking the drug.For James, that was when the problems started. He'd stopped taking the drug after noticing he had less interest in sex - but he says things soon got worse."After about three weeks all hell broke loose. I more or less became completely impotent."He went to see a specialist a few months later."He put me on testosterone therapy, which is a lifelong commitment", says James."Unfortunately that didn't work either. I went back to him six months later and he offered me the chance of a penile implant."There are doctors in Ireland and the US who claim cases like James's aren't unusual and that the drug's labelling is inadequate.Merck say they continually monitor its safety and have recently changed the labelling after reports of sexual side effects continuing after people had stopped taking the drug.They also claim those cases are extremely rare and could be caused by something other than Propecia itself.But James is convinced it was his decision to take the drug that caused his problem."Every day I wish I could turn back the clock."It did work well for my hair, but the cost is ridiculous - losing my sex-life."It's happening to lots and lots of men - and it's about time people woke up to it."Source: Newsbeat
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Tags:
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
World Athletics to introduce standalone World Marathon Championships from 2030
3 minutes -
Africa’s voice in global journalism grows as funding, AI and misinformation shape newsrooms
4 minutes -
First Atlantic Bank holds Annual General Meeting, reports strong growth and bold 2026 outlook
7 minutes -
Ghanaian-founded fintech WeWire secures Canadian PSP license to bridge African, global payments
10 minutes -
Uganda confirms 2027 AFCON dates
18 minutes -
40 convicted in Northern Region crime crackdown
18 minutes -
‘We’re days away from parts of the world experiencing actual shortages:’ Eric Nuttall on energy
28 minutes -
‘I’m Obroni in every country’ – Coco Blasian on music, survival and making Accra home
29 minutes -
IMANI wants NIC to probe possible conflicts of interest in reinsurance arrangements
41 minutes -
First Atlantic Bank strengthens balance sheet as net interest income surges 67%
45 minutes -
Choplife Gaming donates to Korle Bu Radiotherapy unit for Women’s Week 2026
47 minutes -
Would President Mahama have reduced cocoa prices if this were an election year ? – Annoh Dompreh asks
50 minutes -
Passion, not survival, should drive career choice – Dr Kofi Annan
50 minutes -
Climate change, pollution and overfishing push White Volta fishermen to the brink
50 minutes -
IMANI demands review of SIGA directive steering SOEs toward SIC placements
56 minutes